4D Molecular Therapeutics News

4D Molecular Therapeutics | 144/A: Others

Jun 26, 2024 04:46

4D Molecular Therapeutics | ARS: Annual Report to Security Holders

Apr 11, 2024 04:09

4D Molecular Therapeutics | CORRESP: CORRESP

Aug 12, 2023 05:11

4D Molecular Therapeutics | UPLOAD: Others

Aug 11, 2023 23:30

4D Molecular Therapeutics | CORRESP: CORRESP

Sep 2, 2022 04:39

4D Molecular Therapeutics | UPLOAD: Others

Aug 31, 2022 04:30

4D Molecular Therapeutics | CORRESP: CORRESP

Apr 14, 2022 04:43

4D Molecular Therapeutics | UPLOAD: Others

Apr 5, 2022 06:30

4D Molecular Therapeutics | CORRESP: CORRESP

Oct 27, 2021 05:57

4D Molecular Therapeutics | CORRESP: CORRESP

Oct 27, 2021 05:55

4D Molecular Therapeutics | UPLOAD: Others

Oct 14, 2021 01:30

4D Molecular Therapeutics | DRS: Others

Oct 8, 2021 09:34

4D Molecular Therapeutics | UPLOAD: Others

Dec 11, 2020 23:41

4D Molecular Therapeutics | SEC STAFF LETTER: Others

Dec 11, 2020 01:04

4D Molecular Therapeutics | CERT: Others

Dec 10, 2020 22:14

4D Molecular Therapeutics | CORRESP: CORRESP

Dec 9, 2020 06:00

4D Molecular Therapeutics | CORRESP: CORRESP

Dec 9, 2020 05:56

4D Molecular Therapeutics | CORRESP: CORRESP

Dec 7, 2020 19:17

4D Molecular Therapeutics | UPLOAD: Others

Dec 4, 2020 23:54

4D Molecular Therapeutics | SEC STAFF LETTER: Others

Dec 3, 2020 02:44